Developing a National Addiction Treatment Information System: An Introduction to the Drug Evaluation Network System

References 

1. Center for Addiction and Substance Abuse at Columbia University. (1997). National Evaluation of Substance Abuse Treatment Service Delivery Unit Ouestionnaire. New York: Author.
2. Centers for Disease Control. (1997). Youth Risk Behavior National Survey. Available from www.cdc.gov/nccdphp/dash/yrbs/ov.html. Internet source.
3. Department of Health and Human Services. (1981). Regulations by the Department of Health and Human Services (HHS) for Institutional Review Boards and informed consent. From the Federal Register v. 46, #16, 8366. Office of the Secretary, 45 CFR Part 46, 65-77.
4. Fureman I, McLellan AT, Alterman AI. Training for and maintaining interviewer consistency with the ASI. Journal of Substance Abuse Treatment. 1994;11:233–237
   • MEDLINE
   • CrossRef
5. Gottheil E, McLellan AT, Druley KA. Length of stay, patient severity and treatment outcome (Sample data from the field of alcoholism). Journal of Studies on Alcohol. 1992;53:69–75
   • MEDLINE
6. Gustafson JS. Do more and do it better (Staff related issues in the drug treatment field that affect the quality and effectiveness of services. In Improving drug abuse treatment). NIDA Research Monograph. 1991;106:53–56
   • MEDLINE
7. Hubbard RL, Craddock G, Flynn PM, Anderson J, Etheridge R. Overview of 1-year follow-up outcomes in the Drug Abuse Treatment Outcome Study (DATOS). Psychology of Addictive Behavior. 1997;11:261–278
8. Humphreys K, Hamilton EG, Moos RH. Substance abuse treatment in the department of Veterans Affairs (System structure, patients, and treatment activities). Palo Alto, CA: VA Palo Alto Health Care System; 1996;
9. Johnston LD, O'Malley PM, Bachman JG. National survey results on drug use from the Monitoring the Future study, 1975–1995 Vol. II (College students and young adults). Washington, DC: National Institutes of Health; 1997;
10. McCaul ME, Svikis DS. Improving client compliance in outpatient treatment (Counselor-targeted interventions. In Improving drug abuse treatment). NIDA Research Monograph. 1991;106:204–215
    • MEDLINE
11. McLellan AT, Kushner H, Metzger D, Peters R, Grissom G, Pettinati H, et al. The fifth edition of the Addiction Severity Index. Journal of Substance Abuse Treatment. 1992;9:199–213
    • MEDLINE
    • CrossRef
12. McLellan AT, Luborsky L, Cacciola J, Griffith J, Evans F, Barr H, et al. New data from the Addiction Severity Index (Reliability and validity in three centers). Journal of Nervous and Mental Disorders. 1985;173:412–422
13. McLellan AT, Luborsky L, O'Brien CP, Woody GE. An improved diagnostic instrument for substance abuse patients, The Addiction Severity Index. Journal of Nervous and Mental Diseases. 1980;168:26–33
14. McLellan AT, Weisner C. Achieving the public health potential of substance abuse treatment (Implications for patient referral, treatment “matching,” and outcome evaluation). In:  Bickel W,  Degrandpre R editor. Drug policy and human nature. Philadelphia, PA: Wilkins and Wilkins; 1996;p. 233–247
15. National Center for Health Statistics. (1997). Metropolitan areas identifiable in NHIS public use data files. Washington, DC: Author.
16. National Institute on Drug Abuse. (1997a). Monitoring the Future Study, 1975–1996. In NIDA capsules. Available from http://www. nida.nih.gov/NIDACapsules/NCMTFuture.html.Internet source.
17. National Institute on Drug Abuse. (1997b). Epidemiologic trends in drug abuse Vol.1: Highlights and Executive Summary Community Epidemiology Work Group June 1997. Washington, DC: National Institutes of Health.
18. National Institute on Drug Abuse. (1997c). Epidemiologic trends in drug abuse Vol.1: Highlights and Executive Summary Community Epidemiology Work Group December 1996. Washington, DC: National Institutes of Health.
19. Office of National Drug Control Policy. (1997a). The national drug control strategy, 1997. Washington, DC: U.S. Government Printing Office.
20. Office of National Drug Control Policy. (1997b). The national drug control strategy executive overview, 1997. Washington, DC: U.S. Government Printing Office.
21. Simpson DD. Effectiveness of drug abuse treatment (Review of research from field settings. Treating drug abusers effectively). Cambridge, MA: Blackwell; 1997;
22. Substance Abuse and Mental Health Services Administration and Center for Substance Abuse Treatment. (1997). NTIES; The National Treatment Improvement Evaluation Study final report. Chicago, IL: The National Opinion Research Center.
23. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (1996). Preliminary estimates from the 1995 National Household Survey on Drug Abuse. Rockville, MD: Author.
24. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (1997a). National admissions to substance abuse treatment services: The Treatment Episode Data Set (TEDS) 1992–1995. Rockville, MD: Author.
25. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (1997b). Uniform Facility Data Set (UFDS): Data for 1995 and 1980–1995. Rockville, MD: Author.
26. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (1997c). Drug Abuse Warning Network: Annual medical examiner data 1995. Rockville, MD: Author.
27. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. (1997d). Drug abuse warning network: Mid-year preliminary estimates from the 1996 Drug Abuse Warning Network. Rockville, MD: Author.
28. Swindle RW, Peterson KA, Paradise MJ, Moos RH. Measuring substance abuse program treatment orientations (The drug and alcohol program treatment inventory). Journal of Substance Abuse. 1995;7:61–78
    • MEDLINE
    • CrossRef
29. Wright ER, Pescosolido BA, Penslar RL. New ethical challenges to mental health services research in the era of community-based care. Journal of Mental Health Administration. 1997;24:139–151
    • MEDLINE
    • CrossRef